Spruce Biosciences is headquartered in South San Francisco, California.
Spruce Biosciences disclosed revenue of 5M USD for 2024 and 10M USD for 2023.
Spruce Biosciences has 20 employees.
Spruce Biosciences is a life science company.
Spruce Biosciences was founded in 2014.
611 Gateway Boulevard Suite 740,
South San Francisco, California
94080
United States,
(415) 655-4168
www.sprucebio.com
Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with a significant unmet medical need. The company develops tildacerfont, a CRF1 receptor antagonist currently in late-stage trials in adult patients with classic congenital adrenal hyperplasia (CAH), with a planned Phase 2 trial in pediatric classic CAH. Spruce Biosciences was founded in 2014 and is based in South San Francisco, California.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
